<DOC>
	<DOC>NCT00474019</DOC>
	<brief_summary>The purpose of this research study is to evaluate how much of repeated once daily intravenous (IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized children aged 0-17 years old that require acid suppression therapy.</brief_summary>
	<brief_title>Phase 1 Pharmacokinetics of Intravenous Nexium in Children</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>parent/guardian must sign consent form and the child will be asked to sign and Assent Form if he/she is old enough and is able to sign verbal assent will be acceptable if the child is old enough to understand, but unable to write female and/or male hospitalized patients aged 017 years old who should be considered for treatment with acid suppressive therapy. female patients that are pregnant, or plan to become pregnant during the study period or is breastfeeding a child patients with a history of multiple drug allergies any illness, medical history, abnormal laboratory values, abnormal physical examination findings or abnormal vitals signs that could put the patient at risk when participating in the study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>pediatrics</keyword>
	<keyword>neonates</keyword>
</DOC>